Wessex Cardiothoracic Centre, Southampton University Hospitals NHS Trust, Southampton, United Kingdom.
Ann Thorac Surg. 2010 Dec;90(6):1747-52. doi: 10.1016/j.athoracsur.2010.08.002.
The aim of this study was to investigate the early and late outcomes of patients undergoing pulmonary embolectomy for acute massive pulmonary embolus.
Twenty-one patients (15 male, 6 female) underwent pulmonary embolectomy at our institution between March 2001 and July 2010. The median age was 55 years (range, 24 to 70 years). Of these, 9 patients presented with out-of-hospital cardiac arrest and 8 presented with New York Heart Association class III or IV. Sixteen patients underwent preoperative transthoracic echocardiography, which showed evidence of right ventricular dilatation in all, whereas in 14 patients (66.6%) pulmonary artery pressures were significantly elevated with moderate to severe tricuspid regurgitation. The median preoperative Euroscore was 9 (range, 3 to 16), and 11 patients (52.1%) received systemic thrombolysis preoperatively. There were 6 salvage (28.5%), 10 emergency (47.6%), and 5 urgent (23.8%) procedures. Concomitant procedures were performed in 3 patients (14.2%), and surgery was performed without the use of cardiopulmonary bypass in 3 patients (14.2%). The median follow-up was 38 months (range, 0 to 114 months).
The in-hospital mortality was 19% (n = 4). Postoperative complications included stroke (n = 3, 14.2%), lower respiratory tract infection (n = 6, 28.5%), wound infection (n = 3, 14.2%), acute renal failure requiring hemofiltration (n = 4, 19%), and supraventricular tachyarrhythmias (n = 4, 19%). At discharge, transthoracic echocardiography showed mild to moderate right ventricular dysfunction and dilatation in 11 survivors (64.7%). Two patients died during follow-up, and actuarial survival at 5 years was 76.9% ± 10.1% and at 8 years was 51.2% ± 22.0%. At final follow-up, 11 of the 15 survivors (73.3%) were New York Heart Association class I, and no patients required further intervention.
Patients who undergo surgery for massive pulmonary embolism have an acceptable outcome despite being high-risk.
本研究旨在探讨急性大面积肺栓塞患者行肺动脉血栓切除术的早期和晚期结果。
2001 年 3 月至 2010 年 7 月,我院共对 21 例患者(男 15 例,女 6 例)行肺动脉血栓切除术。中位年龄为 55 岁(范围 24 至 70 岁)。其中 9 例患者发生院外心脏骤停,8 例患者出现纽约心脏协会(NYHA)心功能分级Ⅲ或Ⅳ级。16 例患者术前接受经胸超声心动图检查,均显示右心室扩张,其中 14 例(66.6%)肺动脉压力明显升高,伴有中度至重度三尖瓣反流。术前中位 Euroscore 为 9(范围 3 至 16),11 例(52.1%)患者术前接受全身溶栓治疗。行 6 例抢救性(28.5%)、10 例急诊(47.6%)和 5 例紧急(23.8%)手术。3 例(14.2%)患者同时行其他手术,3 例(14.2%)患者在无体外循环下进行手术。中位随访时间为 38 个月(范围 0 至 114 个月)。
院内死亡率为 19%(n=4)。术后并发症包括卒中(n=3,14.2%)、下呼吸道感染(n=6,28.5%)、伤口感染(n=3,14.2%)、需要血液滤过的急性肾功能衰竭(n=4,19%)和室上性心动过速(n=4,19%)。出院时,11 例幸存者(64.7%)经胸超声心动图显示右心室轻至中度功能障碍和扩张。2 例患者在随访期间死亡,5 年和 8 年的生存率分别为 76.9%±10.1%和 51.2%±22.0%。最终随访时,15 例幸存者中有 11 例(73.3%)为纽约心脏协会心功能Ⅰ级,无患者需要进一步介入治疗。
尽管患者风险较高,但接受肺动脉血栓切除术治疗的大面积肺栓塞患者预后可接受。